Categories: News

EADV Congress 2025: Atopic eczema linked to significantly higher risk of suicidal thoughts

PARIS, Sept. 17, 2025 /PRNewswire/ — A new international study presented today at the European Academy of Dermatology and Venereology (EADV) Congress 2025 reveals that adults with atopic eczema (AE) are significantly more likely to experience suicidal thoughts.

- Advertisement -

As one of the largest global investigations to examine the link between AE and suicidal ideation, the “Scars of Life” study surveyed 30,801 adults across 27 countries in 2024. Among them, 15,223 were adults with physician-confirmed current AE, while 7,968 adults without AE served as controls. 

- Advertisement -

Participants with current AE were grouped by age of AE onset – childhood, adolescence, or adulthood – and completed a detailed online questionnaire capturing sociodemographic information, self-reported suicidal ideation, severity of itch and skin pain, AE severity, and experiences of skin-related stigmatisation.

- Advertisement -

The results showed that 13.2% of adults with AE reported suicidal ideation, compared with 8.5% of adults without AE. All AE subgroups – whether the condition began in childhood, adolescence, or adulthood – had higher odds of suicidal ideation than controls.

- Advertisement -

Atopic eczema, a chronic inflammatory skin condition affecting more than 200 million people worldwide, is characterised by recurring episodes of dry, itchy and inflamed skin.Beyond the physical symptoms, its impact on mental health is increasingly recognised, with many experiencing anxiety, depression, and social stigma, alongside the daily challenges of managing their condition.

- Advertisement -

Importantly, the study identified several factors strongly associated with suicidal ideation in adults with AE. Younger adults, particularly those under 30, were more likely to report suicidal thoughts (OR=1.6), as were individuals with obesity (OR=1.29).

- Advertisement -

Clinical features also played a major role: moderate-to-severe AE doubled the odds of suicidal ideation (OR=2.01), while pruritus (itching), skin pain, and high overall symptom intensity were all significantly associated with increased risk.

- Advertisement -

Psychosocial and sleep factors further contributed to risk. Adults with suicidal thoughts reported higher levels of stigmatisation and more prevalent sleep disorders, with mixed insomnia – difficulty falling and staying asleep – notably linked to suicidal ideation (OR=1.78).

- Advertisement -

Dr Delphine Kerob, one of the lead researchers, commented, “The results highlight that the effects of atopic eczema are more than skin deep, with suicidal thoughts representing a serious and frequent concern that is often overlooked by healthcare professionals.”

- Advertisement -

“By identifying the main risk factors behind suicidal ideation in this population, we hope this study will help healthcare professionals better recognise and address these challenges, supporting patients’ overall well-being more effectively.”

- Advertisement -

View original content:https://www.prnewswire.co.uk/news-releases/eadv-congress-2025-atopic-eczema-linked-to-significantly-higher-risk-of-suicidal-thoughts-302555081.html

- Advertisement -

Recent Posts

From Checks to Systems: Regula Recognized Across Key Layers of Identity Verification in 2026 Cybersecurity Excellence Awards

RESTON, Va., April 07, 2026 (GLOBE NEWSWIRE) -- Identity verification (IDV) is shifting from a…

11 hours ago

Naitiv Launches as the First AI-Native ServiceNow Consultancy

Founded by longtime ServiceNow leaders from Thirdera, the firm launches with acquisitions and a strategic…

11 hours ago

IP Strategy Highlights Arias Frontline K-Pop Release with RESCENE on Story

GIG HARBOR, Wash., April 07, 2026 (GLOBE NEWSWIRE) -- IP Strategy Holdings, Inc. (Nasdaq: IPST)…

11 hours ago

Emergent BioSolutions Launches New NARCAN Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness

GAITHERSBURG, Md., April 07, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) today announced…

11 hours ago

NextCure Receives Fast Track Designation for SIM0505 (CDH6 ADC) in Ovarian Cancer

April 07, 2026 08:05 ET  | Source: NextCure The U.S. Food and Drug Administration (FDA)…

11 hours ago

Valitor Announces Oral Presentation at the Upcoming Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting

April 07, 2026 08:00 ET  | Source: Valitor, Inc. BERKELEY, Calif., April 07, 2026 (GLOBE NEWSWIRE)…

11 hours ago